The Changes of Serum Lipoprotein(a) and Plasminogen Activator Inhibitor-1 in Primary Nephrotic Syndrome

International Journal of Sciences
doi 10.18483/ijsci.864
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alkhaer Publications

Related search

Changes in Plasma Levels of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 in Sepsis With Organ Failure.

Nihon Kyukyu Igakukai Zasshi
1994English

The Role of Plasminogen Activator Inhibitor-1 in the Metabolic Syndrome and Its Regulation

Journal of Food Research
2014English

Retraction: The Effects of Residual Platelets in Plasma on Plasminogen Activator Inhibitor-1 and Plasminogen Activator Inhibitor-1-Related Assays

PLoS ONE
Multidisciplinary
2018English

Changes of the Plasma Levels of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 in Cerebral Infarction Induced by the Venous Occlusion.

Japanese Journal of Geriatrics
GerontologyGeriatrics
1995English

Breast Cancer and Metabolic Syndrome Linked Through the Plasminogen Activator Inhibitor-1 Cycle

BioEssays
BiochemistryGeneticsMolecular Biology
2007English

Increased Concentration of Plasminogen Activator Inhibitor-1 and Fibrinogen in Individuals With Metabolic Syndrome

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2009English

Oligofructose Decreases Serum Lipopolysaccharide and Plasminogen Activator Inhibitor-1 in Adults With Overweight/Obesity

Obesity
NutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
2017English

Does Plasminogen Activator Inhibitor-1 Drive Lymphangiogenesis?

PLoS ONE
Multidisciplinary
2010English

Genetics of Plasminogen Activator Inhibitor-1 (PAI-1) in a Ghanaian Population

PLoS ONE
Multidisciplinary
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy